91 related articles for article (PubMed ID: 38753730)
1. Myxomatous mitral valve disease in dogs: does size matter?
Parker HG; Kilroy-Glynn P
J Vet Cardiol; 2012 Mar; 14(1):19-29. PubMed ID: 22356836
[TBL] [Abstract][Full Text] [Related]
2. Myxomatous mitral valve disease in Labrador Retrievers and Golden Retrievers.
Wilson BA; Wesselowski S
J Am Vet Med Assoc; 2024 Jun; ():1-9. PubMed ID: 38906175
[TBL] [Abstract][Full Text] [Related]
3. Genetics of canine myxomatous mitral valve disease.
O'Brien MJ; Beijerink NJ; Wade CM
Anim Genet; 2021 Aug; 52(4):409-421. PubMed ID: 34028063
[TBL] [Abstract][Full Text] [Related]
4. Advances in the understanding of the pathogenesis, progression and diagnosis of myxomatous mitral valve disease in dogs.
Burchell RK; Schoeman J
J S Afr Vet Assoc; 2014 Aug; 85(1):1101. PubMed ID: 25685978
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing provides novel insights into the pathogenesis of naturally occurring myxomatous mitral valve disease stage B1 in beagle dogs.
Kim TS; Hong CY; Oh SJ; Choe YH; Hwang TS; Kim J; Lee SL; Yoon H; Bok EY; Cho AR; Do YJ; Kim E
PLoS One; 2024; 19(5):e0300813. PubMed ID: 38753730
[TBL] [Abstract][Full Text] [Related]
6. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
Li Q; Freeman LM; Rush JE; Laflamme DP
Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868
[TBL] [Abstract][Full Text] [Related]
7. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
Li Q; Heaney A; Langenfeld-McCoy N; Boler BV; Laflamme DP
BMC Vet Res; 2019 Nov; 15(1):425. PubMed ID: 31775756
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
Khaki Z; Nooshirvani P; Shirani D; Masoudifard M
BMC Vet Res; 2022 Dec; 18(1):448. PubMed ID: 36564735
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed platelet activation-related genes in dogs with stage B2 myxomatous mitral valve disease.
Zhou Q; Cui X; Zhou H; Guo S; Wu Z; Li L; Zhang J; Feng W; Guo Y; Ma X; Chen Y; Qiu C; Xu M; Deng G
BMC Vet Res; 2023 Dec; 19(1):271. PubMed ID: 38087280
[TBL] [Abstract][Full Text] [Related]
10. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
Reimann MJ; Cremer S; Christiansen L; Ibragimov E; Gao F; Cirera S; Fredholm M; Olsen LH; Karlskov-Mortensen P
Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19.
Sun Y; Wang G; Wang R; Ren L; Yuan Z; Liu Y; Wu Y; Chen R; Chen Y; Diao B
J Med Microbiol; 2023 Aug; 72(8):. PubMed ID: 37526406
[No Abstract] [Full Text] [Related]
12. Regulation of the JAK/STAT signaling pathway: The promising targets for cardiovascular disease.
Pang Q; You L; Meng X; Li Y; Deng T; Li D; Zhu B
Biochem Pharmacol; 2023 Jul; 213():115587. PubMed ID: 37187275
[TBL] [Abstract][Full Text] [Related]
13. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
Zhou Q; Wu Z; Li L; Zhou H; Chen Y; Guo S; Guo Y; Ma X; Zhang J; Feng W; Cui X; Qiu C; Xu M; Deng G
J Proteomics; 2023 Jun; 282():104924. PubMed ID: 37146676
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
